Literature DB >> 10484499

Organization of rat circadian rhythms during daily infusion of melatonin or S20098, a melatonin agonist.

B Pitrosky1, R Kirsch, A Malan, E Mocaer, P Pevet.   

Abstract

Daily administration of melatonin or S20098, a melatonin agonist, is known to entrain the free-running circadian rhythms of rats. The effects of the duration of administration on entrainment were studied. The animals demonstrated free-running circadian rhythms (running-wheel activity, body temperature, general activity) in constant darkness. Daily infusions of melatonin or S20098 for 1, 8, or 16 h entrained the circadian rhythms to 24 h. Two daily infusions of 1 h (separated by 8 h) entrained the activity peak within the shorter time interval. The entraining properties of melatonin and S20098 were similar and were affected neither by pinealectomy nor by infusion of 1- or 8-h duration. However, with 16-h infusion, less than half of the animals became entrained. Once entrained, the phase angle between the onset of infusion and the rhythms (onset of activity or acrophase of body temperature) increased with the duration of infusion. Before entrainment, the free-running period increased with the duration of infusion, an effect that was not predictable from the phase response curve.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10484499     DOI: 10.1152/ajpregu.1999.277.3.R812

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  18 in total

1.  Circadian clocks in rat skin and dermal fibroblasts: differential effects of aging, temperature and melatonin.

Authors:  Cristina Sandu; Taole Liu; André Malan; Etienne Challet; Paul Pévet; Marie-Paule Felder-Schmittbuhl
Journal:  Cell Mol Life Sci       Date:  2015-01-07       Impact factor: 9.261

2.  Light and melatonin inhibit in vivo serotonergic phase advances without altering serotonergic-induced decrease of per expression in the hamster suprachiasmatic nucleus.

Authors:  Ivette Caldelas; Etienne Challet; Michel Saboureau; Paul Pevet
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

3.  A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation.

Authors:  Michele Fornaro; Davide Prestia; Salvatore Colicchio; Giulio Perugi
Journal:  Curr Neuropharmacol       Date:  2010-09       Impact factor: 7.363

4.  Beneficial Effects of Exogenous Melatonin in Acute Staphylococcus aureus and Escherichia coli Infection-Induced Inflammation and Associated Behavioral Response in Mice After Exposure to Short Photoperiod.

Authors:  Biswadev Bishayi; Rana Adhikary; Ajeya Nandi; Sahin Sultana
Journal:  Inflammation       Date:  2016-12       Impact factor: 4.092

5.  Time-shifting effects of methylphenidate on daily rhythms in the diurnal rodent Arvicanthis ansorgei.

Authors:  Jorge Mendoza; Hester C van Diepen; Rob Rodrigues Pereira; Johanna H Meijer
Journal:  Psychopharmacology (Berl)       Date:  2018-05-18       Impact factor: 4.530

6.  Agomelatine treatment corrects impaired sleep-wake cycle and sleep architecture and increases MT1 receptor as well as BDNF expression in the hippocampus during the subjective light phase of rats exposed to chronic constant light.

Authors:  Jana Tchekalarova; Lidia Kortenska; Natasha Ivanova; Milena Atanasova; Pencho Marinov
Journal:  Psychopharmacology (Berl)       Date:  2019-11-13       Impact factor: 4.530

Review 7.  Agomelatine, the first melatonergic antidepressant: discovery, characterization and development.

Authors:  Christian de Bodinat; Béatrice Guardiola-Lemaitre; Elisabeth Mocaër; Pierre Renard; Carmen Muñoz; Mark J Millan
Journal:  Nat Rev Drug Discov       Date:  2010-06-25       Impact factor: 84.694

Review 8.  Agomelatine: mechanism of action and pharmacological profile in relation to antidepressant properties.

Authors:  B Guardiola-Lemaitre; C De Bodinat; P Delagrange; M J Millan; C Munoz; E Mocaër
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

9.  Melatonin.

Authors:  Paul Pévet
Journal:  Dialogues Clin Neurosci       Date:  2002-03       Impact factor: 5.986

10.  Disturbances of diurnal phase markers, behavior, and clock genes in a rat model of depression; modulatory effects of agomelatine treatment.

Authors:  K Højgaard; S L Christiansen; E V Bouzinova; O Wiborg
Journal:  Psychopharmacology (Berl)       Date:  2017-11-19       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.